This inventor holds 1 USPTO granted patent. Top assignee: Cadila Healthcare Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Mind of Dharmendra Arvindbhai Darji
Introduction: Dharmendra Arvindbhai Darji is a notable inventor from Gujarat, India, recognized for his significant contributions to the field of pharmaceutical sciences. With a keen focus on innovative compounds, he has made strides that highlight his expertise and dedication to research.
Latest Patents: Dharmendra holds a patent for his work on a pyrrole compound which encompasses compositions and processes for preparation thereof. The patent describes compositions comprising saroglitazar magnesium, notable for its high purity of greater than or equal to 99% by weight. It also involves a dimer compound of Formula (IV) present in minimal amounts, making it a valuable addition to pharmaceutical compositions. This innovative approach not only enhances the efficacy of the compounds but also represents a significant advancement in pharmaceutical formulations.
Career Highlights: Currently, Dharmendra is associated with Cadila Healthcare Limited, where he contributes to various research initiatives. His role in the company exemplifies his commitment to advancing healthcare through innovative solutions. His expertise and research acumen have played a pivotal role in the development of new pharmaceutical products that can improve patient outcomes.
Collaborations: Throughout his career, Dharmendra has worked alongside esteemed colleagues such as Sanjay Jagdish Desai and Ramesh Chandra Singh. These collaborations have enriched his work and have led to the successful development of impactful innovations in the pharmaceutical industry.
Conclusion: Dharmendra Arvindbhai Darji stands as an inspiring figure in the realm of inventions, particularly in pharmaceuticals. His patent on pyrrole compounds exemplifies his dedication to enhancing healthcare through scientific innovation. With continued research and collaborations, Dharmendra is poised to remain a key contributor to the advancement of medical science and pharmaceutical developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile